Recurrently Predicting Hypergraphs

This work considers predicting the relational structure of a hypergraph for a given set of vertices, as common for applications in particle physics, biological systems and other complex combinatorial problems. A problem arises from the number of possible multi-way relationships, or hyperedges, scaling in $\mathcal{O}(2^n)$ for a set of $n$ elements. Simply storing an indicator tensor for all relationships is already intractable for moderately sized $n$, prompting previous approaches to restrict the number of vertices a hyperedge connects. Instead, we propose a recurrent hypergraph neural network that predicts the incidence matrix by iteratively refining an initial guess of the solution. We leverage the property that most hypergraphs of interest are sparsely connected and reduce the memory requirement to $\mathcal{O}(nk)$, where $k$ is the maximum number of positive edges, i.e., edges that actually exist. In order to counteract the linearly growing memory cost from training a lengthening sequence of refinement steps, we further propose an algorithm that applies backpropagation through time on randomly sampled subsequences. We empirically show that our method can match an increase in the intrinsic complexity without a performance decrease and demonstrate superior performance compared to state-of-the-art models

Self-Guided Diffusion Models

Diffusion models have demonstrated remarkable progress in image generation quality, especially when guidance is used to control the generative process. However, guidance requires a large amount of image-annotation pairs for training and is thus dependent on their availability, correctness and unbiasedness. In this paper, we eliminate the need for such annotation by instead leveraging the flexibility of self-supervision signals to design a framework for self-guided diffusion models. By leveraging a feature extraction function and a self-annotation function, our method provides guidance signals at various image granularities: from the level of holistic images to object boxes and even segmentation masks. Our experiments on single-label and multi-label image datasets demonstrate that self-labeled guidance always outperforms diffusion models without guidance and may even surpass guidance based on ground-truth labels, especially on unbalanced data. When equipped with self-supervised box or mask proposals, our method further generates visually diverse yet semantically consistent images, without the need for any class, box, or segment label annotation. Self-guided diffusion is simple, flexible and expected to profit from deployment at scale

Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles.

We have reported previously that the anti-emetic efficacy of single agent 5HT3 antagonists is not maintained when analysed with the measurement of cumulative probabilities. Presently, the most effective anti-emetic regimen is a combination of a 5HT3 antagonist plus dexamethasone. We, therefore, assessed the sustainment of efficacy of such a combination in 125 patients, scheduled to receive cisplatin > or = 70 mg m(-2) either alone or in combination with other cytotoxic drugs. Anti-emetic therapy was initiated with 10 mg of dexamethasone and 3 mg of granisetron intravenously, before cisplatin. On days 1-6, patients received 8 mg of dexamethasone and 1 mg of granisetron twice daily by oral administration. Protection was assessed during all cycles and calculated based on cumulative probability analyses using the method of Kaplan-Meier and a model for transitional probabilities. Irrespective of the type of analysis used, the anti-emetic efficacy of granisetron/dexamethasone decreased over cycles. The initial complete acute emesis protection rate of 66% decreased to 30% according to the method of Kaplan-Meier and to 39% using the model for transitional probabilities. For delayed emesis, the initial complete protection rate of 52% decreased to 21% (Kaplan-Meier) and to 43% (transitional probabilities). In addition, we observed that protection failure in the delayed emesis period adversely influenced the acute emesis protection in the next cycle. We conclude that the anti-emetic efficacy of a 5HT3 antagonist plus dexamethasone is not maintained over multiple cycles of highly emetogenic chemotherapy, and that the acute emesis protection is adversely influenced by protection failure in the delayed emesis phase

Incremental concept learning with few training examples and hierarchical classification

Object recognition and localization are important to automatically interpret video and allow better querying on its content. We propose a method for object localization that learns incrementally and addresses four key aspects. Firstly, we show that for certain applications, recognition is feasible with only a few training samples. Secondly, we show that novel objects can be added incrementally without retraining existing objects, which is important for fast interaction. Thirdly, we show that an unbalanced number of positive training samples leads to biased classi er scores that can be corrected by modifying weights. Fourthly, we show that the detector performance can deteriorate due to hard-negative mining for similar or closely related classes (e.g., for Barbie and dress, because the doll is wearing a dress). This can be solved by our hierarchical classi cation. We introduce a new dataset, which we call TOSO, and use it to demonstrate the e ectiveness of the proposed method for the localization and recognition of multiple objects in images.This research was performed in the GOOSE project, which is jointly funded by the enabling technology program Adaptive Multi Sensor Networks (AMSN) and the MIST research program of the Dutch Ministry of Defense. This publication was supported by the research program Making Sense of Big Data (MSoBD).peer-reviewe

Action recognition by layout, selective sampling and softassignment

Abstrac

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Suppression of the secretion of prolactin, growth hormone and insulin-like growth factor 1 (IGF-1) might be important in the growth regulation and treatment of breast cancer. Because oestrogens may counteract the anti-tumour effects of such treatment, the combination of an anti-oestrogen (tamoxifen), a somatostatin analogue (octreotide) and a potent anti-prolactin (CV 205-502) might be attractive. In this respect, we performed a first exploratory long-term study on the feasibility of combined treatment and possible clear differences in endocrine and anti-tumour effects during such combined treatment vs standard treatment with tamoxifen alone. Twenty-two post-menopausal patients with metastatic breast cancer (ER and/or PR positive or unknown) were randomized to receive either 40 mg of tamoxifen per day or the combination of 40 mg of tamoxifen plus 75 microg of CV 205-502 orally plus 3 x 0.2 mg of octreotide s.c. as first-line endocrine therapy. An objective response was found in 36% of the patients treated with tamoxifen alone and in 55% of the patients treated with combination therapy. Median time to progression was 33 weeks for patients treated with tamoxifen and 84 weeks for patients treated with combination therapy, but the numbers are too small for hard conclusions. There was no difference in overall post-relapse survival between the two treatment arms. With respect to the endocrine parameters, there was a significant decrease of plasma IGF-1 levels in both treatment arms, whereas during combined treatment plasma growth hormone tended to decrease and plasma prolactin levels were strongly suppressed; in some patients insulin and transforming growth factor alpha (TGF-alpha) decreased during the triple therapy. Although there was no significant difference in mean decrease of plasma IGF-1 levels between the two treatment arms, combined treatment resulted in a more uniform suppression of IGF-1. Therefore, the addition of a somatostatin analogue and an anti-prolactin may potentially enhance the efficacy of anti-oestrogens in the treatment of breast cancer owing to favourable endocrine and possible direct anti-tumour effects. Large phase III trials using depot formulations (to increase the feasibility) of somatostatin analogues are warranted to demonstrate the potential extra beneficial anti-tumour effects of such combination therapy

Data Augmentations in Deep Weight Spaces

Learning in weight spaces, where neural networks process the weights of other deep neural networks, has emerged as a promising research direction with applications in various fields, from analyzing and editing neural fields and implicit neural representations, to network pruning and quantization. Recent works designed architectures for effective learning in that space, which takes into account its unique, permutation-equivariant, structure. Unfortunately, so far these architectures suffer from severe overfitting and were shown to benefit from large datasets. This poses a significant challenge because generating data for this learning setup is laborious and time-consuming since each data sample is a full set of network weights that has to be trained. In this paper, we address this difficulty by investigating data augmentations for weight spaces, a set of techniques that enable generating new data examples on the fly without having to train additional input weight space elements. We first review several recently proposed data augmentation schemes %that were proposed recently and divide them into categories. We then introduce a novel augmentation scheme based on the Mixup method. We evaluate the performance of these techniques on existing benchmarks as well as new benchmarks we generate, which can be valuable for future studies.Comment: Accepted to NeurIPS 2023 Workshop on Symmetry and Geometry in Neural Representation